Advisornet Financial’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
HWAM
VCM
ATC
FFO
EP
TWD
TCM
Advisornet Financial's FLGT Position: Q3 2026 in Review
Advisornet Financial sold out of Fulgent Genetics (FLGT) in Q3 2026, closing a stake of 24 shares — an estimated $492 sold.
Advisornet Financial first reported a position in FLGT in Q4 2021 and held it in 19 quarters. The position peaked at $5K in Q2 2022. 10 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.
- Advisornet Financial reported no remaining Fulgent Genetics position as of Q3 2026 after selling out during the quarter.
- Advisornet Financial sold 24 Fulgent Genetics shares in Q3 2026, an estimated $492.
- Advisornet Financial first reported a position in Fulgent Genetics in Q4 2021 and held it in 19 quarters.
- Advisornet Financial's Fulgent Genetics position peaked at $5K in Q2 2022.
- 10 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.
Based on Advisornet Financial's 13F filing for Q3 2026, filed 15 Oct 2026.